First and foremost, it’s important to evaluate the reasons for pursuing a clinical elective in the US. Personally, I had been set on completing my specialty training (residency) in the US since my third year of medical school, and an...
Age-related macular degeneration (AMD) is a neurodegenerative complex disease of the eye and a major cause of blindness and visual impairment among the elderly worldwide. The early stages of the disease are characterised by asymptomatic pigmentary abnormalities and accumulation of...
Charity SeeAbility and Willow Dene Oakmere Road special school in Greenwich were delighted to host the first practising optometrist MP to be elected to parliament, Shockat Adam, to see the charity’s eyecare work in action. Shockat came to learn more...
A highly sought after accredited virtual course delivered by world-renowned experts at Moorfields Eye Hospital and UCL Institute of Ophthalmology. Course structureThis course will feature live on-line lectures by an international faculty, interactive question and answer sessions and case discussions....
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...
The past 25 years have seen remarkable advances in clinical eye care for children in the UK. This has led to both improved outcomes and better patient and family experiences. There have been substantial changes to patient pathways, major advances...
Disability charity SeeAbility has launched a new short film for Learning Disability Week to raise awareness of how people with learning disability can get support with eyecare. The charity works to remove the barriers to eye care for people with...
Optical Express has become the official headline sponsor of a rowing challenge that will see Jason Black (52) and Neil Glover (60) row over 3100 miles across the Atlantic Ocean, in an effort to raise money to fund groundbreaking research into a cure for dementia.
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...